Glen Bradley does not plan to stand for re-election as director of Alimera Sciences Inc. at the company's 2018 annual meeting of stockholders.
Bradley has served as a board member of the company since 2011.
Alpharetta, Ga.-based Alimera is a pharmaceutical company, dealing in the research, development and commercialization of prescription ophthalmic pharmaceuticals, focusing on diseases affecting the back of the eye or retina.
